Revenue GrowthSustained, rapid top-line growth demonstrates strong market adoption of HeartFlow's FFRCT service and other CT-based analytics. A per-study revenue model benefits from volume scaling: as more providers adopt CCTA workflows, recurring per-patient revenues can compound and support durable expansion over multiple quarters.
High, Improving Gross MarginsElevated and rising gross margins indicate attractive unit economics consistent with a software-enabled diagnostic service. High contribution margins support operating leverage: as volumes grow, incremental revenue can flow disproportionately to operating margin expansion and eventual profitability if fixed costs are controlled.
Lower Leverage / Healthier 2025 Balance SheetA materially lower debt load and positive equity in the latest reported year reduce near-term solvency risk and financing pressure. Manageable leverage increases flexibility for R&D and commercialization investments and lowers near-term refinancing needs, supporting multi-quarter execution of growth initiatives.